Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
- Registration Number
- NCT01179412
- Lead Sponsor
- Mahidol University
- Brief Summary
The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.
- Detailed Description
The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 172
Inclusion Criteria
- patients who were diagnosed with EKC at the outpatient ophthalmic unit
Exclusion Criteria
- children younger than six years
- women being pregnant or during lactation
- history of allergy to povidone-iodine
- prior ocular surgery
- contact lens usage and chronic eye diseases with current eye medications.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 2% povidone-iodine 2% povidone-iodine -
- Primary Outcome Measures
Name Time Method the recovery rate within one week of treatment 1 week
- Secondary Outcome Measures
Name Time Method drug tolerability 1 week proportion of patient who can continue topical application of povidone-iodine for a week or until EKC subsides
Trial Locations
- Locations (1)
Department of Ophthalmology, Siriraj Hospital Mahidol University
🇹ðŸ‡Bangkoknoi, Bangkok, Thailand